NCT07177287

Brief Summary

This randomized controlled trial aims to evaluate the effect of a navigator nurse-supported mobile application, developed based on the Information-Motivation-Behavioral Skills (IMB) model, on the quality of life of adult patients newly diagnosed with celiac disease. Participants will be randomized into intervention and control groups. The intervention group will use the mobile application with navigator nurse support for six months, while the control group will receive routine clinical education. Outcomes will be assessed through validated questionnaires and clinical data.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 10, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 16, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Completed
Last Updated

July 17, 2026

Status Verified

September 1, 2025

Enrollment Period

6 months

First QC Date

September 10, 2025

Last Update Submit

July 16, 2026

Conditions

Keywords

quality of lifenavigator nursemobile applicationIMB model

Outcome Measures

Primary Outcomes (1)

  • Improving the quality of life of celiac patients

    Change in quality of life scores measured by a validated questionnaire for celiac disease patients (e.g., Celiac Disease Quality of Life Survey) from baseline to the end of the intervention. Health-Related Quality of Life Questionnaire in Celiac Disease: The questionnaire was developed by Hauser et al. and validated in Turkey by Aksan et al. It assesses how adult celiac patients have felt over the past two weeks by asking about disease-related symptoms, general well-being, and emotional state. The questionnaire consists of 28 items, evaluated across four subscales: emotional, social, gastrointestinal, and worries. Each item is rated on a 7-point Likert scale. Participants can score a minimum of 0 and a maximum of 49 points in each subscale. The total score ranges between 0 and 196, with lower scores reflecting lower quality of life.

    6 months

Secondary Outcomes (3)

  • Adherence to Gluten-Free Diet

    6 months

  • Patient Motivation Level

    6 months

  • Patient Engagement with the Mobile Application

    6 months

Study Arms (2)

Experimental: Navigator nurse-supported mobile application (IMB Model)

EXPERIMENTAL

Participants receiving the navigator nurse-supported mobile application based on the IMB model.

Behavioral: IMB navigator app

Control: Standard care without mobile application

NO INTERVENTION

Participants receiving standard care without the mobile application.

Interventions

Mobile application developed based on the IMB model, supported by a navigator nurse. Includes educational content, reminders and behavioral support. Patients will be followed for 6 months.

Experimental: Navigator nurse-supported mobile application (IMB Model)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years
  • Newly diagnosed with celiac disease
  • Owning a smartphone and able to use the application
  • Able to speak and understand Turkish
  • Voluntary participation (informed consent)

You may not qualify if:

  • Severe gluten hypersensitivity
  • Withdrawal of consent during the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Etlik City Hospital

Ankara, Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Celiac Disease

Condition Hierarchy (Ancestors)

Malabsorption SyndromesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Hilal TÜZER

    Faculty of Health Sciences, Ankara Yıldırım Beyazıt University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Nurse / MSN (Master of Science in Nursing)

Study Record Dates

First Submitted

September 10, 2025

First Posted

September 16, 2025

Study Start

August 1, 2025

Primary Completion

February 1, 2026

Study Completion

June 1, 2026

Last Updated

July 17, 2026

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations